IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition

The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metasta...

Full description

Saved in:
Bibliographic Details
Published inOncology letters Vol. 13; no. 6; pp. 4657 - 4660
Main Authors Shang, Guan-Sheng, Liu, Lunxu, Qin, Yi-Wei
Format Journal Article
LanguageEnglish
Published Greece Spandidos Publications UK Ltd 01.06.2017
D.A. Spandidos
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer.
AbstractList The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer.
The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer.The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor necrosis factor (TNF)-α regulate the proliferation of lung cancer. However, few studies have focused on the effects of IL-6 and TNF-α on metastasis of lung cancer. The present study was designed to investigate whether IL-6 and TNF-α can promote metastasis of non-small cell lung cancer (NSCLC). Sixty-five tumor and matched adjacent tissue samples from patients with NSCLC and corresponding serum samples were collected. Thirty serum samples from healthy subjects were selected as controls. Real-time PCR and western blot analysis were used to measure IL-6, TNF-α, vimentin, E-cadherin, and N-cadherin expression in tissue samples; ELISA was used to measure IL-6 and TNF-α expression in serum samples. The correlation of serum levels of IL-6 and TNF-α with the clinical stage was analyzed; the correlation of IL-6 and TNF-α levels in serum with these tissues was analyzed; the correlation of serum levels of IL-6 and TNF-α with lymph node metastasis and distant metastasis was analyzed. Expression of IL-6 and TNF-α were significantly increased compared with controls in both serum and tissue; IL-6 and TNF-α levels were positively correlated with lymph node metastasis and distant metastasis; IL-6 and TNF-α levels were negatively correlated with E-cadherin level and were positively correlated with N-cadherin and vimentin levels. In conclusion, IL-6 and TNF-α can induce epithelial-mesenchymal transition, and subsequently promote metastasis of lung cancer. Anti-inflammation should be considered for the treatment of lung cancer.
Author Shang, Guan-Sheng
Liu, Lunxu
Qin, Yi-Wei
AuthorAffiliation 2 Department of Intensive Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
1 Department of Thoracic Surgery, West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China
AuthorAffiliation_xml – name: 2 Department of Intensive Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, P.R. China
– name: 1 Department of Thoracic Surgery, West China School of Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Author_xml – sequence: 1
  givenname: Guan-Sheng
  surname: Shang
  fullname: Shang, Guan-Sheng
– sequence: 2
  givenname: Lunxu
  surname: Liu
  fullname: Liu, Lunxu
– sequence: 3
  givenname: Yi-Wei
  surname: Qin
  fullname: Qin, Yi-Wei
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28599466$$D View this record in MEDLINE/PubMed
BookMark eNptkc9KHTEUxkNRqrXuui4BN110rkluJplsBJHaChfd6DpkMme8kUxym8wI97F8kT5TM_gHFUMgh-R3Pr585wvaCTEAQt8oWSwbxY6jXzBC5UIQ3nxC-1QqVlHSsJ2XWvI9dJjzHSmrFrRpxGe0x5paKS7EPtIXq0pgEzp8fXle_XvAmxSHOAIeYDS5bJdx7LGfwi22JlhIuN1iF7rJunIFGzeuwTvjqwEyBLveDsbjMZmQ3ehi-Ip2e-MzHD6dB-jm_Nf12Z9qdfX74ux0VVlO2VgBE7aTdUuI7TgF0_FO1LZRkhIlgfZtK3uhOOkZsW2rBEBHaSsNVczWyqjlATp51N1M7QCdhVA8eL1JbjBpq6Nx-u1LcGt9G-91zWtWsigCP54EUvw7QR714LIF702AOGVNFWn4kjAlCnr0Dr2LUwrle4VSvAQr61nw-2tHL1aesy8AewRsijkn6LV1o5lDKwad15ToecY6ej3PWM8zLk0_3zU9636I_weGCqlB
CitedBy_id crossref_primary_10_1016_j_phymed_2019_152848
crossref_primary_10_1016_j_prp_2023_155038
crossref_primary_10_1080_19490976_2020_1737487
crossref_primary_10_1111_cpr_12776
crossref_primary_10_1007_s12672_022_00467_4
crossref_primary_10_1016_j_yexcr_2019_05_011
crossref_primary_10_1089_dna_2019_4620
crossref_primary_10_1038_s41388_022_02376_w
crossref_primary_10_3390_antiox12071327
crossref_primary_10_3389_fendo_2023_1154741
crossref_primary_10_3390_molecules24224100
crossref_primary_10_1007_s10517_025_06343_9
crossref_primary_10_1080_08916934_2018_1477133
crossref_primary_10_1155_2018_7152962
crossref_primary_10_3390_molecules24183393
crossref_primary_10_1134_S1990519X23060111
crossref_primary_10_1158_1535_7163_MCT_19_0168
crossref_primary_10_12677_tcm_2024_1310412
crossref_primary_10_3390_cells10051024
crossref_primary_10_1111_cas_16064
crossref_primary_10_1016_j_resp_2022_103979
crossref_primary_10_1016_j_plefa_2022_102426
crossref_primary_10_1111_cbdd_70014
crossref_primary_10_1186_s12917_024_04429_6
crossref_primary_10_3390_cancers13010143
crossref_primary_10_1007_s12032_024_02422_5
crossref_primary_10_3390_cells14060400
crossref_primary_10_1016_j_ecoenv_2024_117617
crossref_primary_10_1016_j_biopha_2023_115222
crossref_primary_10_3389_fonc_2022_969396
crossref_primary_10_3390_ijms221810172
crossref_primary_10_1002_jcb_29883
crossref_primary_10_2174_1573394717666210705115359
crossref_primary_10_1007_s00335_020_09846_0
crossref_primary_10_3390_ijms22168691
crossref_primary_10_1016_j_yexcr_2021_112779
crossref_primary_10_1038_s41598_024_57852_y
crossref_primary_10_18699_SSMJ20230202
crossref_primary_10_1080_13880209_2021_2016866
crossref_primary_10_1016_j_semcancer_2017_10_005
crossref_primary_10_3390_biom10121676
crossref_primary_10_4103_jcrt_jcrt_2225_22
crossref_primary_10_1186_s12957_023_03247_8
crossref_primary_10_1155_2023_3144086
crossref_primary_10_1186_s12885_023_11585_9
crossref_primary_10_1111_1759_7714_15220
crossref_primary_10_1016_j_addr_2021_113918
crossref_primary_10_1016_j_jddst_2023_104375
crossref_primary_10_1038_s41571_021_00564_3
crossref_primary_10_1155_2021_6644018
crossref_primary_10_36106_8014846
crossref_primary_10_1016_j_semcancer_2021_01_003
crossref_primary_10_3389_fpls_2023_1114398
crossref_primary_10_3389_fonc_2024_1428003
crossref_primary_10_3390_ijms25115727
crossref_primary_10_3389_fcimb_2019_00112
crossref_primary_10_1186_s12885_019_5353_6
crossref_primary_10_3390_cancers16061113
crossref_primary_10_1186_s12957_023_02945_7
crossref_primary_10_18036_aubtdc_412520
crossref_primary_10_1007_s10555_021_10017_z
crossref_primary_10_1155_2020_2658795
crossref_primary_10_3390_pathogens13111005
crossref_primary_10_3390_cancers15030729
crossref_primary_10_1016_j_semcdb_2021_04_001
crossref_primary_10_1016_j_jss_2024_11_003
crossref_primary_10_1080_14789450_2021_1892491
crossref_primary_10_1007_s00432_021_03644_0
crossref_primary_10_1002_ijc_32624
crossref_primary_10_1038_s41418_023_01149_6
crossref_primary_10_1002_jbt_22553
crossref_primary_10_1002_jev2_12326
crossref_primary_10_2217_fon_2021_1304
crossref_primary_10_3390_ijms242417325
crossref_primary_10_1021_acsami_4c09065
crossref_primary_10_3390_ijms24010252
crossref_primary_10_32604_or_2023_030690
crossref_primary_10_1016_j_amsu_2018_10_024
crossref_primary_10_1186_s12876_023_02870_9
crossref_primary_10_1002_1878_0261_12620
crossref_primary_10_1038_s41467_022_33719_6
crossref_primary_10_1155_2021_5595520
crossref_primary_10_2174_0113816128330427241017110325
crossref_primary_10_1016_j_cyto_2022_156039
crossref_primary_10_1155_2020_7658342
Cites_doi 10.3109/01902140903042589
10.1016/j.jtho.2016.05.021
10.1016/j.lfs.2016.04.023
10.1002/mc.22471
10.1186/s12935-016-0323-4
10.18632/oncotarget.10088
10.1016/j.jtho.2016.05.025
10.18632/oncotarget.10243
10.1093/jb/mvr136
10.1517/14622416.3.6.763
10.18632/oncotarget.6570
10.1016/j.cllc.2016.05.015
10.3390/ijms161226215
10.1186/s13287-015-0179-x
10.1016/j.bcp.2016.06.014
10.3892/or.2016.4897
10.1186/1471-2407-13-496
10.18632/oncotarget.9319
ContentType Journal Article
Copyright Copyright Spandidos Publications UK Ltd. 2017
Copyright: © Shang et al. 2017
Copyright_xml – notice: Copyright Spandidos Publications UK Ltd. 2017
– notice: Copyright: © Shang et al. 2017
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.3892/ol.2017.6048
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
ProQuest One Health & Nursing
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central (New)
ProQuest One Academic
ProQuest Central (Alumni)
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1792-1082
EndPage 4660
ExternalDocumentID PMC5452994
28599466
10_3892_ol_2017_6048
Genre Journal Article
GeographicLocations Beijing China
United States--US
China
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GroupedDBID ---
0R~
53G
7X7
8FI
8FJ
AAKDD
AAYXX
ABDBF
ABJNI
ABUWG
ACGFS
ACUHS
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BENPR
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
EBD
EBS
EJD
ESX
F5P
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IHW
IPNFZ
ITC
O9-
OK1
OVD
PHGZM
PHGZT
PQQKQ
PROAC
RIG
RPM
TEORI
UKHRP
W2D
NPM
3V.
7XB
8FK
K9.
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c412t-e26cd75b00cd41ead4d65c8971097e1fbb7f6940f20cbb96eed11b7a192c59a93
IEDL.DBID 7X7
ISSN 1792-1074
IngestDate Thu Aug 21 14:34:04 EDT 2025
Thu Jul 10 22:33:41 EDT 2025
Fri Jul 25 08:11:13 EDT 2025
Thu Apr 03 07:08:11 EDT 2025
Tue Jul 01 01:58:28 EDT 2025
Thu Apr 24 23:05:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 6
Keywords lung cancer
epithelial-mesenchymal transition
tumor necrosis factor-α
interleukin-6
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c412t-e26cd75b00cd41ead4d65c8971097e1fbb7f6940f20cbb96eed11b7a192c59a93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5452994
PMID 28599466
PQID 1994946754
PQPubID 2044954
PageCount 4
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5452994
proquest_miscellaneous_1908430296
proquest_journals_1994946754
pubmed_primary_28599466
crossref_citationtrail_10_3892_ol_2017_6048
crossref_primary_10_3892_ol_2017_6048
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-06-01
PublicationDateYYYYMMDD 2017-06-01
PublicationDate_xml – month: 06
  year: 2017
  text: 2017-06-01
  day: 01
PublicationDecade 2010
PublicationPlace Greece
PublicationPlace_xml – name: Greece
– name: Athens
PublicationTitle Oncology letters
PublicationTitleAlternate Oncol Lett
PublicationYear 2017
Publisher Spandidos Publications UK Ltd
D.A. Spandidos
Publisher_xml – name: Spandidos Publications UK Ltd
– name: D.A. Spandidos
References Chen (key20180108113702_b10-ol-0-0-6048) 2016
Ninsontia (key20180108113702_b9-ol-0-0-6048) 2016; 16
Rhee (key20180108113702_b16-ol-0-0-6048) 2015; 16
Ge (key20180108113702_b12-ol-0-0-6048) 2016; 153
Hsiao (key20180108113702_b11-ol-0-0-6048) 2016; 7
Bo (key20180108113702_b13-ol-0-0-6048) 2013; 13
Cheng (key20180108113702_b1-ol-0-0-6048) 2016; 11
Pore (key20180108113702_b4-ol-0-0-6048) 2016; 17
Rahman (key20180108113702_b6-ol-0-0-6048) 2016; 7
Lee (key20180108113702_b14-ol-0-0-6048) 2016; 7
Shintani (key20180108113702_b5-ol-0-0-6048) 2016; 11
Sarries (key20180108113702_b2-ol-0-0-6048) 2002; 3
Wang (key20180108113702_b17-ol-0-0-6048) 2015; 6
Emmons (key20180108113702_b7-ol-0-0-6048) 2016; 122
Fan (key20180108113702_b8-ol-0-0-6048) 2016; 36
Zhou (key20180108113702_b15-ol-0-0-6048) 2016; 7
Song (key20180108113702_b19-ol-0-0-6048) 2016; 56
Kawata (key20180108113702_b18-ol-0-0-6048) 2012; 151
Yamauchi (key20180108113702_b20-ol-0-0-6048) 2010; 36
Sharma (key20180108113702_b3-ol-0-0-6048) 2015; 11
References_xml – volume: 36
  start-page: 12
  year: 2010
  ident: key20180108113702_b20-ol-0-0-6048
  article-title: Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1
  publication-title: Exp Lung Res
  doi: 10.3109/01902140903042589
– volume: 11
  start-page: 1653
  year: 2016
  ident: key20180108113702_b1-ol-0-0-6048
  article-title: The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.05.021
– year: 2016
  ident: key20180108113702_b10-ol-0-0-6048
  article-title: miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells
  publication-title: Oncotarget
– volume: 153
  start-page: 1
  year: 2016
  ident: key20180108113702_b12-ol-0-0-6048
  article-title: Diosmetin prevents TGF-β1-induced epithelial-mesenchymal transition via ROS/MAPK signaling pathways
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2016.04.023
– volume: 56
  start-page: 36
  year: 2016
  ident: key20180108113702_b19-ol-0-0-6048
  article-title: Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22471
– volume: 16
  start-page: 48
  year: 2016
  ident: key20180108113702_b9-ol-0-0-6048
  article-title: Zinc induces epithelial to mesenchymal transition in human lung cancer H460 cells via superoxide anion-dependent mechanism
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-016-0323-4
– volume: 7
  start-page: 44417
  year: 2016
  ident: key20180108113702_b11-ol-0-0-6048
  article-title: SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.10088
– volume: 11
  start-page: 1482
  year: 2016
  ident: key20180108113702_b5-ol-0-0-6048
  article-title: IL-6 secreted from cancer associated fibroblasts mediates chemoresistance in non-small-cell lung cancer by increasing epithelial-mesenchymal transition signaling
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2016.05.025
– volume: 7
  start-page: 54852
  year: 2016
  ident: key20180108113702_b6-ol-0-0-6048
  article-title: Lung cancer exosomes as drivers of epithelial mesenchymal transition
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.10243
– volume: 151
  start-page: 205
  year: 2012
  ident: key20180108113702_b18-ol-0-0-6048
  article-title: TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells
  publication-title: J Biochem
  doi: 10.1093/jb/mvr136
– volume: 3
  start-page: 763
  year: 2002
  ident: key20180108113702_b2-ol-0-0-6048
  article-title: Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
  publication-title: Pharmacogenomics
  doi: 10.1517/14622416.3.6.763
– volume: 7
  start-page: 6626
  year: 2016
  ident: key20180108113702_b14-ol-0-0-6048
  article-title: IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.6570
– volume: 11
  start-page: 1033
  year: 2015
  ident: key20180108113702_b3-ol-0-0-6048
  article-title: Lung cancer screening: history, current perspectives, and future directions
  publication-title: Arch Med Sci
– volume: 17
  start-page: 535
  year: 2016
  ident: key20180108113702_b4-ol-0-0-6048
  article-title: Cancer stem cells, epithelial to mesenchymal markers, and circulating tumor cells in small cell lung cancer
  publication-title: Clin Lung Cancer
  doi: 10.1016/j.cllc.2016.05.015
– volume: 16
  start-page: 30015
  year: 2015
  ident: key20180108113702_b16-ol-0-0-6048
  article-title: Mesenchymal stem cell-mediated effects of tumor support or suppression
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms161226215
– volume: 6
  start-page: 185
  year: 2015
  ident: key20180108113702_b17-ol-0-0-6048
  article-title: Differentially expressed microRNAs in bone marrow mesenchymal stem cell-derived microvesicles in young and older rats and their effect on tumor growth factor-β1-mediated epithelial-mesenchymal transition in HK2 cells
  publication-title: Stem Cell Res Ther
  doi: 10.1186/s13287-015-0179-x
– volume: 122
  start-page: 1
  year: 2016
  ident: key20180108113702_b7-ol-0-0-6048
  article-title: The role of phenotypic plasticity in the escape of cancer cells from targeted therapy
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2016.06.014
– volume: 36
  start-page: 1016
  year: 2016
  ident: key20180108113702_b8-ol-0-0-6048
  article-title: Atorvastatin partially inhibits the epithelial-mesenchymal transition in A549 cells induced by TGF-β1 by attenuating the upregulation of SphK1
  publication-title: Oncol Rep
  doi: 10.3892/or.2016.4897
– volume: 13
  start-page: 496
  year: 2013
  ident: key20180108113702_b13-ol-0-0-6048
  article-title: Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-13-496
– volume: 7
  start-page: 41294
  year: 2016
  ident: key20180108113702_b15-ol-0-0-6048
  article-title: Mesenchymal stem cells promote pancreatic adenocarcinoma cells invasion by transforming growth factor-β1 induced epithelial-mesenchymal transition
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.9319
SSID ssj0000561886
Score 2.4124806
Snippet The characteristics of cancer cells, such as invasiveness, are affected by the tumor microenvironment. Studies have shown that interleukin (IL)-6 and tumor...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 4657
SubjectTerms Chemotherapy
Cytokines
Drug resistance
Gene expression
Laboratories
Lung cancer
Medical prognosis
Metastasis
Oncology
Proteins
Tumor necrosis factor-TNF
Tumors
Title IL-6 and TNF-α promote metastasis of lung cancer by inducing epithelial-mesenchymal transition
URI https://www.ncbi.nlm.nih.gov/pubmed/28599466
https://www.proquest.com/docview/1994946754
https://www.proquest.com/docview/1908430296
https://pubmed.ncbi.nlm.nih.gov/PMC5452994
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB5BKyEuiH9CS2UkOCHTxHHs-IQAdVUQXSHUSnuL4p-0lXaTpZs99LH6IjwTM0k2sCA4x5Ydz9gznvn8DcCrSufOCIq44_2HSyEst4ro8YxOpfE-7UMDJ1N1fCY_z7LZEHBbDbDKzZnYHdS-cRQjPyQOWyoHn8l3y--cqkZRdnUooXEbdom6jCBdeqbHGAt5x3lX7BHVTnDCHvbYd7TS4rChzEOi3-LU8m2r9Jer-Sdi8jcTNLkP9wbfkb3vhf0AboX6Idw5GbLjj6D49IUrVtaenU4n_McNW3ZYu8AWoS3RC1xdrlhTsTnub-ZI2lfMXjO8lK-x_zkLS3qfMUeF5At6k-Qurhc4XEvWrAN2PYazydHpx2M-FFDgTiai5UEo53WGO8t5maDOSK8ylxvCX-qQVNbqShkZVyJ21hqF9jJJrC7R63OZKU36BHbqpg7PgGVxhZ6dVzZzWuZVal2OvlviQ0pl8MoqgjebBSzcwC5ORS7mBd4yaLmLZl7Qche03BG8Hlsve1aNf7Tb38iiGPbWqvilCRG8HD_jrqBUR1mHZk1t4lymsTAqgqe96MaBiLKPWPUj0FtCHRsQ4_b2l_ryomPepoLs2Pf5_6e1B3fpD3pA2T7stFfr8AJdl9YedPp5ALsfjqZfv_0EzrnvXA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwEB6tuhJwQbwJLGAk9oTMJo7zOiDEY6uWbSuEutLeQvwIW6lNyjYV6p9C4o_wm5hJ0kBBcNuzx3IyHo8_e8bfADzLo1gngm7c8fzDpRCKq5Do8ZLIl4kxfnM1MJ6Eg1P5_iw424Nv27cwlFa59Ym1ozalpjvyI-KwpXLwgXy1_MKpahRFV7clNBqzOLGbr3hkW70cvsP5PRSifzx9O-BtVQGupScqbkWoTRSguWkjPVSkNGGg44SSEiPr5UpFeZhINxeuVioJcRPxPBVlCIV0kGREvoQuf1_6eJTpwf6b48mHj92tDuHxuC4viYYuOGU7Ntn2iAvEUUmxDi96gcqId_fBv8Dtnzmav216_RtwvUWr7HVjXjdhzxa34Mq4jcffhnQ44iHLCsOmkz7_8Z0t6-w-yxa2yhB3rmYrVuZsjh6FabKvC6Y2bFaYNfb_zOySXoTMcQnwBb2C0uebBQ5X0f5Zp5LdgdNLUe5d6BVlYe8DC9wcsaQJVaAjGee-0jGiRc9YnwrvZbkDz7cKTHXLZ05lNeYpnmtI3Wk5T0ndKanbgcNOetnwePxD7mA7F2m7mlfpL9tz4GnXjOuQgitZYcs1ybix9F2RhA7ca6auG4hIAonH34FoZ1I7AeL43m0pZuc11zeVgMe-D_7_WU_g6mA6HqWj4eTkIVyjv2nS2Q6gV12s7SMETpV63Forg0-XvUB-AmdcLO4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRaq4IN4EChiJnpDZjePEyQEhRFl1abvi0Ep7C_Ej7Uq7ydLNCu3P4sqP4DcxkxcsCG4925aT8Yz92f78DcDLXMUmEXTijvsfLoXQXEckj5eoQCbWBs3RwOkkOjqXH6fhdAe-d29hiFbZzYn1RG1LQ2fkA9KwpXTwoRzkLS3i0-Ho7fILpwxSdNPapdNoXOTYbb7i9m31ZnyIY30gxOjD2fsj3mYY4Eb6ouJORMaqEF3PWOmjUaWNQhMnRFBUzs-1VnmUyGEuhkbrJMIFxfe1yhAWmTDJSIgJp_8bKgh9ijE1Vf35DiHzuE40iS4vOPEeG949IgQxKOnWw1ev0Szx9or4F8z9k6352_I3ug23WtzK3jWOdgd2XHEX9k7bm_l7kI5PeMSywrKzyYj_-MaWNc_PsYWrMkSgq9mKlTmb49zCDHnaFdMbNivsGttfMLektyFzDAa-oPdQ5nKzwO4qWklrUtl9OL8W0z6A3aIs3CNg4TBHVGkjHRol4zzQJkbc6FsXUAq-LPfgVWfA1LTK5pRgY57iDofMnZbzlMydkrk9OOhrLxtFj3_U2-_GIm3jepX-8kIPXvTFGJF0zZIVrlxTnWEsg6FIIg8eNkPXd0RygaTo74HaGtS-Aql9b5cUs8ta9ZuSwWPbx___rOewh2GRnownx0_gJv1Mw2vbh93qau2eIoKq9LPaVRl8vu7Y-AkCPS--
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-6+and+TNF-%CE%B1+promote+metastasis+of+lung+cancer+by+inducing+epithelial-mesenchymal+transition&rft.jtitle=Oncology+letters&rft.au=Shang%2C+Guan-Sheng&rft.au=Liu%2C+Lunxu&rft.au=Qin%2C+Yi-Wei&rft.date=2017-06-01&rft.pub=D.A.+Spandidos&rft.issn=1792-1074&rft.eissn=1792-1082&rft.volume=13&rft.issue=6&rft.spage=4657&rft.epage=4660&rft_id=info:doi/10.3892%2Fol.2017.6048&rft_id=info%3Apmid%2F28599466&rft.externalDocID=PMC5452994
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-1074&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-1074&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-1074&client=summon